Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: A Mid-Atlantic Oncology Program study

This publication has 19 references indexed in Scilit:

• Chemotherapy for pancreatic carcinoma
  Cancer, 1996
• Estimates of the worldwide incidence of eighteen major cancers in 1985
  International Journal of Cancer, 1993
• A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.
  Journal of Clinical Oncology, 1989
• Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
  Journal of Clinical Oncology, 1986
• Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.
  Proceedings of the National Academy of Sciences, 1986
• Chemotherapy for advanced pancreatic cancer.A comparison of 5-fluorouracil, adriamycin, and mitomycin (fam) with 5-fluorouracil, streptozotocin, and mitomycin (fsm)
  Cancer, 1986
• Current status of chemotherapy for advanced pancreatic and gastric cancer.
  Journal of Clinical Oncology, 1985
• Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin
  Cancer, 1985
• 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas
  Cancer, 1980
• Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer
  Cancer, 1978